National Healthcare/$NHC
1D1W1MYTD1Y5YMAX
Capital at risk
About National Healthcare
National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.
- Ticker
- $NHC
- Sector
- Health
- Primary listing
- AMEX
- Employees
- 15,278
- Headquarters
- Murfreesboro, United States
- Website
- www.nhccare.com
NHC Metrics
BasicAdvanced
$3.5B
25.46
$8.90
0.64
$2.59
1.18%
Price and volume
Market cap
$3.5B
Beta
0.64
52-week high
$239.29
52-week low
$114.59
Average daily volume
104K
Dividend rate
$2.59
Financial strength
Current ratio
1.862
Quick ratio
1.473
Long term debt to equity
0.012
Total debt to equity
0.028
Dividend payout ratio (TTM)
28.36%
Interest coverage (TTM)
56.65%
Profitability
EBITDA (TTM)
190.397
Gross margin (TTM)
39.49%
Net profit margin (TTM)
9.00%
Operating margin (TTM)
9.28%
Effective tax rate (TTM)
22.94%
Revenue per employee (TTM)
$100,000
Management effectiveness
Return on assets (TTM)
5.84%
Return on equity (TTM)
13.27%
Valuation
Price to earnings (TTM)
25.459
Price to revenue (TTM)
2.258
Price to book
3.16
Price to tangible book (TTM)
3.81
Price to free cash flow (TTM)
24.027
Free cash flow yield (TTM)
4.16%
Free cash flow per share (TTM)
9.431
Dividend yield (TTM)
1.14%
Forward dividend yield
1.18%
Growth
Revenue change (TTM)
6.92%
Earnings per share change (TTM)
32.85%
3-year revenue growth (CAGR)
12.77%
10-year revenue growth (CAGR)
5.45%
3-year earnings per share growth (CAGR)
62.50%
10-year earnings per share growth (CAGR)
10.11%
3-year dividend per share growth (CAGR)
4.04%
10-year dividend per share growth (CAGR)
4.61%
Bulls say / Bears say
National Healthcare’s net operating revenues for Q2 2026 rose 8.8 percent year-over-year to $408.03 million, driven by acquisitions of five skilled nursing facilities. (PublicNow)
GAAP diluted earnings per share for Q2 2026 climbed to $2.54 from $1.52 in the prior-year period, a 67 percent increase reflecting robust profitability growth. (PublicNow)
In May 2026, NHC entered a credit agreement securing a $475 million senior unsecured term loan and a $50 million revolving credit facility with Bank of America to fund its expansion and strengthen liquidity. (Reuters)
CMS’s Skilled Nursing Facility Value-Based Purchasing program is estimated to reduce Medicare payments to skilled nursing facilities by $208.4 million in fiscal year 2026, offsetting reimbursement gains and pressuring margins. (CMS)
The proposed rule for fiscal year 2027 updates the SNF Prospective Payment System by just 2.4 percent after a 0.8 percent productivity adjustment—down from a 3.2 percent increase in fiscal year 2026—signaling slower future reimbursement growth. (CMS)
The U.S. government’s six-month moratorium on new Medicare enrollments for home healthcare and hospice providers, announced in May 2026, will restrict expansion of NHC’s homecare and hospice segments. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 5 Sept 2026.
NHC Financial Performance
Revenues and expenses
Upcoming events
NHC News
AllArticlesVideos
Funds containing NHC
AllUSDGBPEUR
Fund name | Fund size | $NHC weighting |
|---|---|---|
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.16% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.16% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.10% |
iShares MSCI World Small Cap$WSML | $9B | 0.03% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.03% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.